Daunomycin Medicines

Daunomycin Medicines

Product Details:

  • Salt Composition Daunorubicin hydrochloride
  • Dosage Form Injection
  • Indication Antineoplastic agent for the treatment of acute leukemia
  • Enzyme Types Anthracycline glycoside antibiotics
  • Feature High purity, stable formulation, ready for intravenous use
  • Ingredients Daunorubicin hydrochloride, excipients
  • Application Oncology
  • Click to View more
X

Daunomycin Medicines Price And Quantity

Daunomycin Medicines Product Specifications

  • Neutral (approximately 7)
  • Anthracycline glycoside antibiotics
  • Injection
  • Oncology
  • Non-enzymatic
  • Daunorubicin hydrochloride
  • Odorless
  • Not applicable (synthetic production)
  • Antineoplastic agent for the treatment of acute leukemia
  • Store in a refrigerator between 2C and 8C. Protect from light.
  • High purity, stable formulation, ready for intravenous use
  • Daunorubicin hydrochloride, excipients
  • Red crystalline powder
  • 24 months

Daunomycin Medicines Trade Information

  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

These medicines are effective in the treatment of kaposis sarcoma. With healthy experience of several years and complete knowledge of the industry, we are engaged in offering Daunomycin Medicines. Doctors use is with other cancer medications to subside the progression of cancers of the white blood cell.Highly demanded in the market, these medicines come in different strengths of dosage. We offer Daunomycin Medicines at market leading prices to clients.

Features:

  • Accurate composition
  • Low chances of side effects
  • Effective antineoplastic agent

INDICATORS

  • Pregnancy:D Lactation:L4 Lab:NA Food:NATYPICAL USAGE
  • Acute leukemia, HIV related kaposis sarcoma.




Targeted Therapy for Acute Leukemia

Daunomycin is specifically indicated for the treatment of acute lymphocytic and myeloid leukemia. Acting as an antineoplastic agent, it plays a vital role in induction therapy during oncology protocols, directly targeting malignant cells by interfering with DNA synthesis and enzymatic activity.


Premium Purity and Stable Formulation

This product boasts a purity of greater than 99%, ensuring reliable performance and consistent therapeutic results. Daunomycin is provided in ready-to-use sterile vials, and its stability allows for refrigerated storage between 2C and 8C, safeguarding its potency throughout its 24-month shelf life.


Safe Handling and Administration Guidelines

As a cytotoxic drug, Daunomycin requires careful handling using gloves and protective clothing to minimize occupational exposure. The red crystalline powder must be reconstituted with sterile water prior to intravenous administration, ensuring accurate dosing and patient safety within healthcare settings.

FAQs of Daunomycin Medicines:


Q: How should Daunomycin be stored to maintain its effectiveness?

A: Daunomycin vials should be kept refrigerated between 2C and 8C and protected from light, preserving their stability and extending the shelf life up to 24 months.

Q: What is the recommended process for reconstituting Daunomycin prior to use?

A: To prepare Daunomycin for intravenous administration, dissolve the red crystalline powder in sterile water for injection according to clinical guidelines, ensuring the solution is clear before use.

Q: When is Daunomycin typically prescribed in clinical oncology?

A: Daunomycin is commonly used during induction therapy for patients diagnosed with acute lymphocytic or myeloid leukemia, helping to reduce malignant cell populations during initial cancer treatment stages.

Q: Where is Daunomycin administered and by which route?

A: Daunomycin is administered in clinical or hospital settings via intravenous injection to ensure precise dosing and professional monitoring of patient response.

Q: What handling precautions must be followed with Daunomycin?

A: Because Daunomycin is cytotoxic, healthcare professionals should always wear gloves and protective clothing when handling the drug to avoid any accidental exposure.

Q: How does Daunomycin benefit patients with acute leukemia?

A: By intercalating DNA and inhibiting topoisomerase II, Daunomycin disrupts cancer cell replication, offering a targeted approach to reduce leukemia cell numbers and improve patient outcomes during chemotherapy.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Injections' category



We Mainly Deal in International Market.
Back to top